Wiley Jenny L
Department of Pharmacology and Toxicology, Virginia Commonwealth University, P.O. Box 980613, Richmond, Virginia 23298-0613, USA.
Eur J Pharmacol. 2008 Jan 14;578(2-3):216-21. doi: 10.1016/j.ejphar.2007.09.010. Epub 2007 Sep 26.
Schizophrenia is a serious psychiatric disorder that is most frequently treated with the administration of antipsychotics. Although onset of schizophrenia typically occurs in late adolescence, the majority of preclinical research on the behavioral effects of antipsychotics and their mechanism(s) of action has been conducted on adult male animals. In this study, the acute effects of haloperidol (0.03-0.3 mg/kg, i.p.) and clozapine (1-10 mg/kg, i.p.) on locomotor activity were examined in juvenile [postnatal day 22 (PN22)], adolescent (PN40), and adult (>PN70) rats of both sexes. Subsequently, in order to determine whether tolerance to the activity suppressive effects of these drugs would occur in adolescents, PN40 rats were dosed and assessed for an additional nine days. While all groups exhibited some degree of suppression following acute administration of both drugs, juvenile rats were considerably more sensitive to this effect. With sub-chronic administration during late adolescent development (PN40-PN49), tolerance failed to develop. These results emphasize the importance of age in pharmacological characterization of antipsychotics and suggest that pre-adolescents may have enhanced sensitivity to the motor effects of these drugs. Further, they suggest that, similar to adults, older adolescents may not develop tolerance to the activity suppression induced by these two antipsychotics.
精神分裂症是一种严重的精神疾病,最常通过使用抗精神病药物进行治疗。尽管精神分裂症通常在青春期后期发病,但大多数关于抗精神病药物行为效应及其作用机制的临床前研究是在成年雄性动物身上进行的。在本研究中,研究了氟哌啶醇(0.03 - 0.3毫克/千克,腹腔注射)和氯氮平(1 - 10毫克/千克,腹腔注射)对幼年[出生后第22天(PN22)]、青春期(PN40)和成年(>PN70)雌雄大鼠运动活动的急性影响。随后,为了确定青少年是否会对这些药物的活动抑制作用产生耐受性,对PN40大鼠给药并在接下来的九天进行评估。虽然在急性给予两种药物后所有组都表现出一定程度的抑制,但幼年大鼠对这种作用更为敏感。在青春期后期发育阶段(PN40 - PN49)进行亚慢性给药时,耐受性并未形成。这些结果强调了年龄在抗精神病药物药理学特征中的重要性,并表明青春期前儿童可能对这些药物的运动效应具有更高的敏感性。此外,结果表明,与成年人一样,年龄较大的青少年可能不会对这两种抗精神病药物引起的活动抑制产生耐受性。